Displaying 3930 results out of a total of 3930 publications.
N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
Jin, H;Ying, X;Que, B;Wang, X;Chao, Y;Zhang, H;Yuan, Z;Qi, D;Lin, S;Min, W;Yang, M;Ji, W;
EBioMedicine, EBioMedicine ():, 2019
View publication
EBioMedicine, EBioMedicine ():, 2019
Low expression of ANT1 confers oncogenic properties to rhabdomyosarcoma tumor cells via modulating metabolism and death pathways.
Vial, J;Huchede, P;Fagault, S;Basset, F;Rossi, M;
bioRxiv, bioRxiv ():, 2020
View publication
bioRxiv, bioRxiv ():, 2020
Atomized Human Amniotic Mesenchymal Stromal Cells for Direct Delivery to the Airway for Treatment of Lung Injury
Kim, SY;Burgess, JK;Wang, Y;Kable, EP;Weiss, DJ;Chan, HK;Chrzanowski, W;
J Aerosol Med Pulm Drug Deliv, J Aerosol Med Pulm Drug Deliv ():, 2016
View publication
J Aerosol Med Pulm Drug Deliv, J Aerosol Med Pulm Drug Deliv ():, 2016
Pharmacologic control of CAR-T cell function using dasatinib
Weber, EW;Lynn, RC;Sotillo, E;Lattin, J;Xu, P;Mackall, CL;
Blood Adv, Blood Adv 3(5):711-717, 2019
View publication
Blood Adv, Blood Adv 3(5):711-717, 2019
Chidamide increases the sensitivity of non-small cell lung cancer to crizotinib by decreasing c-MET mRNA methylation
Ding, N;You, A;Tian, W;Gu, L;Deng, D;
bioRxiv, bioRxiv ():, 2020
View publication
bioRxiv, bioRxiv ():, 2020
CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer
Benkheil, M;Van Haele, M;Roskams, T;Laporte, M;Noppen, S;Abbasi, K;Delang, L;Neyts, J;Liekens, S;
Exp. Cell Res., Exp. Cell Res. 372(2):168-177, 2018
View publication
Exp. Cell Res., Exp. Cell Res. 372(2):168-177, 2018
Poly (I:C) and LPS induce distinct immune responses by ovarian stromal fibroblasts
Patel, MV;Shen, Z;Wira, CR;
J. Reprod. Immunol., J. Reprod. Immunol. 127():36-42, 2018
View publication
J. Reprod. Immunol., J. Reprod. Immunol. 127():36-42, 2018
A genome-wide loss-of-function screen identifies SLC26A2 as a novel mediator of TRAIL resistance
Dimberg, L;Towers, CG;Behbakht, K;Hotz, T;Kim, J;Fosmire, SP;Porter, CC;Tan, AC;Thorburn, A;Ford, HL;
Mol. Cancer Res, Mol. Cancer Res ():, 2017
View publication
Mol. Cancer Res, Mol. Cancer Res ():, 2017
miR-762 Promotes Malignant Development of Head and Neck Squamous Cell Carcinoma by Targeting PHLPP2 and FOXO4
Chen, S;Zhang, JY;Sun, LS;Li, XF;Bai, JY;Zhang, HY;Li, TJ;
Onco Targets Ther, Onco Targets Ther 12():11425-11436, 2019
View publication
Onco Targets Ther, Onco Targets Ther 12():11425-11436, 2019
ERBB3 and IGF1R signaling are required for Nrf2-dependent growth in KEAP1-mutant lung cancer
Vartanian, S;Lee, J;Klijn, C;Gnad, F;Bagniewska, M;Schaefer, G;Zhang, D;Tan, J;Watson, SA;Liu, L;Chen, H;Liang, Y;Watanabe, C;Cuellar, T;Kan, D;Hartmaier, RJ;Lau, T;Costa, MR;Martin, SE;Merchant, M;Haley, B;Stokoe, D;
Cancer Res., Cancer Res. ():, 2019
View publication
Cancer Res., Cancer Res. ():, 2019